Exponential Biotherapies, Inc. Email Format
Hospitals and Health CareVirginia, United States2-10 Employees
Exponential Biotherapies, Inc. is a biotechnology company based in McLean, Virginia. The firm is developing EA-230, an intravenously administered peptide derived from a human pregnancy hormone and intended to modulate immune responses. A September 2021 news item notes EA-230 as an active development program. The company is a small, U.S.-based organization focused on immunomodulatory therapies within the healthcare and biotechnology landscape. Its website is expobio.com for additional information.